<p>A: vaccinated at 3 week intervals with 1790GAHB containing 29 ng or 1859 ng protein. B: at day 21 following a single injection of 1790GAHB containing 29, 116, 465 or 1859 ng protein. This is the result from a potency study; half the mice were vaccinated with the appropriate doses of a formulation of 1790GAHB prepared from the reference batch of 1790-GMMA stored at -80°C (blue, +) and formulated 2 days before vaccination. The other mice were vaccinated with appropriate doses of the NVGH 1790GAHB vaccine stability batch (red, X). All doses contained the same amount of Alhydrogel in 0.5 mL buffered saline.</p
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>Groups of BALB/c mice (n = 10) were vaccinated once (graphs on left) or twice (graphs on right) w...
<p>(<b>A</b>) Study design: Balb/c mice were vaccinated with NH36sap, F1sap, F2sap or F3sap at the i...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>Serum levels of total IgG (green triangles), IgG1 (black circles) and IgG2a (red circles) were me...
<p>(A). Dose-dependent HA vaccine antigens were administered with 10 μg poly(I:C) resolved in 5 μl o...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
<p>Groups of 60 female BALB/c mice received either two doses given three weeks apart of 10<sup>6</su...
<p><b>A</b> Groups of six-weeks old female BALB/c mice (n = 4) were immunized subcutaneously once wi...
<p>rGAPDH-specific IgG titers of 4 female Balb/c mice per group, immunized three times with a three ...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
(A) Vaccine schedule to measure efficacy and post-challenge anamnestic response in male AKR/J mice. ...
<p>Groups of BALB/c mice (n = 10) were vaccinated once (graphs on left) or twice (graphs on right) w...
<p>BALB/c mice were vaccinated by the subcutaneous route three times every three weeks with either 2...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>Groups of BALB/c mice (n = 10) were vaccinated once (graphs on left) or twice (graphs on right) w...
<p>(<b>A</b>) Study design: Balb/c mice were vaccinated with NH36sap, F1sap, F2sap or F3sap at the i...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>Serum levels of total IgG (green triangles), IgG1 (black circles) and IgG2a (red circles) were me...
<p>(A). Dose-dependent HA vaccine antigens were administered with 10 μg poly(I:C) resolved in 5 μl o...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
<p>Groups of 60 female BALB/c mice received either two doses given three weeks apart of 10<sup>6</su...
<p><b>A</b> Groups of six-weeks old female BALB/c mice (n = 4) were immunized subcutaneously once wi...
<p>rGAPDH-specific IgG titers of 4 female Balb/c mice per group, immunized three times with a three ...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
(A) Vaccine schedule to measure efficacy and post-challenge anamnestic response in male AKR/J mice. ...
<p>Groups of BALB/c mice (n = 10) were vaccinated once (graphs on left) or twice (graphs on right) w...
<p>BALB/c mice were vaccinated by the subcutaneous route three times every three weeks with either 2...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>Groups of BALB/c mice (n = 10) were vaccinated once (graphs on left) or twice (graphs on right) w...
<p>(<b>A</b>) Study design: Balb/c mice were vaccinated with NH36sap, F1sap, F2sap or F3sap at the i...